Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating YL201 in combination with toripalimab, with or without cisplatin, for recurrent or metastatic nasophar…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC [Phase 3]
Phase 3 clinical trial comparing IMRT or IMPT plus CIRT for nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical study is evaluating hetrombopag for preventing chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma patients…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial [NA]
Prospective Phase II trial evaluating tislelizumab in combination with chemotherapy and response-adapted radiotherapy for de novo metastatic…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Adaptive Immunotherapy for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update for adaptive immunotherapy targeting nasopharyngeal carcinoma, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC [Phase 3]
Phase 3 clinical trial evaluating concurrent chemoradiotherapy with or without metronomic capecitabine for high-risk nasopharyngeal carcinom…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy [Phase 2]
Phase II study evaluating HLX43 in recurrent/metastatic nasopharyngeal carcinoma patients who failed or were intolerant to second-line thera…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
Prospective study profiling immuno-radiomic features in nasopharyngeal carcinoma patients treated with proton or photon chemoradiotherapy; c…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase III clinical trial is testing EBV-DNA-guided adaptive immunotherapy for advanced nasopharyngeal carcinoma; the study is not yet recr…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China
This clinical trial aims to validate the 9th edition AJCC staging system for nasopharyngeal carcinoma in non-high-incidence areas of China; …
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies [Phase 2]
Phase 2 clinical trial update of VK 2019, a novel EBNA1 inhibitor, in EBV-positive nasopharyngeal carcinoma and other EBV-associated cancers…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial evaluating SSTR2 imaging with [68Ga]Ga-DOTA-TOC PET/CT in nasopharyngeal carcinoma; recruitment is cu…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma
A clinical trial update exploring molecular predictors of efficacy and new therapeutic targets for nasopharyngeal carcinoma, currently not r…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating an intranasal corticosteroid spray to prevent otitis media with effusion after radiotherapy in nasopharyng…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors [Phase 2]
Phase 2 clinical trial update for SI-B003 and the BL-B01D1+SI-B003 combination in locally advanced or metastatic non-small cell lung cancer,…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating nimotuzumab in combination with a TGP regimen as first-line therapy for recurrent or metastatic nasophar…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial [Phase 2]
This Phase II Bayesian adaptive trial investigates a combination therapy for PD-1 resistant recurrent or metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial update describes testing serplulimab with induction chemotherapy and radiotherapy for locally advanced nasopharynge…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy [Phase 3]
Phase 3 clinical trial update on reducing target volumes for nasopharyngeal carcinoma treated with induction chemotherapy followed by concur…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating perioperative chemotherapy and immunotherapy for locally recurrent nasopharyngeal carcinoma; the …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating toripalimab with induction chemotherapy and radiation therapy including omega-3 for locally advanced nasop…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating intensity-modulated radiotherapy (IMRT) with lobaplatin-based concurrent chemoradiation for nasopharyngeal carcin…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma [Phase 2]
A phase 2 study is evaluating whether prophylactic neck irradiation can be omitted in nasopharyngeal carcinoma when toripalimab is given in …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma
Clinical trial examining a watch-and-wait strategy after immunochemotherapy for locally recurrent nasopharyngeal carcinoma; recruitment has …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC [Phase 2]
A Phase 2 clinical trial assessing the combination of QL1706 (Iparomlimab/Tuvorlimab) with a modified TPF induction regimen for locally adva…